Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06006884 · ClinicalTrials.gov registry record
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
A clinical trial of COVID-19, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06006884 is a study of COVID-19 that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 75 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06006884, a study of COVID-19, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
Conditions Studied
Interventions
- PROCEDURE Bronchoscopies and Bronchoalveolar Lavages (BALs)
- DIAGNOSTIC_TEST Chest Tomography (CT)
- DIAGNOSTIC_TEST Electrocardiogram (ECG)
- DIAGNOSTIC_TEST Pulmonary function tests (PFTs)
- DIAGNOSTIC_TEST 6 minute walk test (6MWT)
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06006884
The ClinicalTrials.gov registry entry for NCT06006884 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 5 interventions - of which Bronchoscopies and Bronchoalveolar Lavages (BALs) is the first listed.
NCT06006884 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06006884 about?
NCT06006884 is a clinical study titled "A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae". The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
What is the current status of trial NCT06006884?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-01-10. Estimated completion is 2027-08.
What conditions does trial NCT06006884 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT06006884?
The interventions under investigation include: Bronchoscopies and Bronchoalveolar Lavages (BALs) (PROCEDURE), Chest Tomography (CT) (DIAGNOSTIC_TEST), Electrocardiogram (ECG) (DIAGNOSTIC_TEST), Pulmonary function tests (PFTs) (DIAGNOSTIC_TEST), 6 minute walk test (6MWT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06006884?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06006884 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.